A way to read further

Our source notes.

A company page describes a service. A medical source gives clinical context. Our articles distinguish those roles and link the evidence behind particular statements.

1. Provider product and care information

   CoreAge Rx: estrogen assessment and treatment page ↗

   Checked 2026-09-27

2. Provider access and pricing information

   Evernow: care options, membership and pay-per-visit ↗

   Checked 2026-09-27

3. Provider treatment page

   Evernow: hormone therapy and pharmacy options ↗

   Checked 2026-09-27

4. Provider appointment and billing information

   Midi: HRT appointments, costs and coverage ↗

   Checked 2026-09-27

5. Provider care process

   Midi: preparing for menopause care ↗

   Checked 2026-09-27

6. Federal patient and labeling guidance

   FDA: Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms ↗

   Checked 2026-09-27

7. Professional patient guidance

   ACOG: Hormone Therapy for Menopause ↗

   Checked 2026-09-27

8. UK public health guidance

   NHS: Postmenopausal bleeding ↗

   Checked 2026-09-27

9. Federal regulatory explanation

   FDA: Understanding the Risks of Compounded Drugs ↗

   Checked 2026-09-27

10. US National Institutes of Health patient guidance

    National Institute on Aging: Sleep Problems and Menopause: What Can I Do? ↗

    Checked 2026-09-27

11. Professional society consensus statement abstract hosted by PubMed

    The 2022 hormone therapy position statement of The North American Menopause Society: published abstract ↗

    Checked 2026-09-27

12. UK public health patient guidance

    NHS: Vaginal dryness ↗

    Checked 2026-09-27

13. Manufacturer product labeling

    Pfizer: Estring prescribing information, April 2026 revision ↗

    Checked 2026-09-27

14. US National Library of Medicine hosted product labeling

    DailyMed: Femring estradiol acetate vaginal ring label; record updated December 2025, prescribing information revised November 2023 ↗

    Checked 2026-09-27

15. US professional society patient guidance

    ACOG: Perimenopausal Bleeding and Bleeding After Menopause ↗

    Checked 2026-09-27

16. US regulator labeling announcement

    FDA: Initial six menopausal hormone therapy labeling changes approved February 12, 2026 ↗

    Checked 2026-09-27

17. US professional society patient guidance

    ACOG: Abnormal Uterine Bleeding ↗

    Checked 2026-09-27